Filing Details

Accession Number:
0001140361-12-030372
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-18 17:52:35
Reporting Period:
2012-06-15
Filing Date:
2012-06-18
Accepted Time:
2012-06-18 17:52:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070698 Raptor Pharmaceutical Corp RPTP Pharmaceutical Preparations (2834) 860883978
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420859 E Thomas Daley C/O Raptor Pharmaceutical Corp.
9 Commercial Blvd., Suite 200
Novato CA 94949
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-06-15 3,333 $5.77 94,905 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2012.
  2. This transaction was executed in multiple trades at prices ranging from $5.71 to $5.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.